Copyright © 2018 ALM Media Properties, LLC. All Rights Reserved.
The odds were daunting: AbbVie Inc. was facing its third bellwether trial over its prescription testosterone supplement Androgel, and it was up to Kirkland & Ellis partner James Hurst to turn the tide.
*May exclude premium content
Already have an account? Sign In Now
Interested in customizing your subscription with Law.com All Access?
Contact our Sales Professionals at 1-855-808-4530 or send an email to firstname.lastname@example.org to learn more.
Jenna Greene is editor of The Litigation Daily and author of the "Daily Dicta" column. She is based in the San Francisco Bay Area and can be reached at email@example.com or 240 460-4444.